NEMLUVIO relieves itch fast, with skin healing that lasts1-3

Approved for eczema (atopic dermatitis) and prurigo nodularis4

      

Not actual patients.

  • Fast itch relief, in 
    some people as 
    soon as 48 hours1*

  • Itch relief that lasts so skin can heal2,3

  • Long-lasting 
    skin clearance2,3

  • Fewer sleepless 
    nights5

  • Favorable 
    safety profile4

  • ~Once-monthly 
    dosing from the 
    start4

Results were achieved at 48 hours in 10.7% of AD patients with NEMLUVIO + TCS/TCI vs 2.9% with placebo + TCS/TCI and 17.2% of PN patients with Nemluvio vs 3.7% with placebo. Data are from pooled post-hoc analysis of daily itch improvement reported in Phase 3 clinical studies. Itch improvement was defined as ≥4‑point improvement from baseline (PP‑NRS scale). Do not make conclusions based on these results. Individual results may vary.1

GPS (Galderma Patient Services) for NEMLUVIO™ logo.

Here to help navigate your experience from the start, discover the dedicated services and support team through GPS (Galderma Patient Services) for NEMLUVIO™.

EXPLORE GPS FOR NEMLUVIO 

CONNECT WITH US TO LEARN MORE

Sign up to learn more about getting started with NEMLUVIO.

SIGN UP 

AD=atopic dermatitis; PP-NRS=Peak Pruritus Numerical Rating Scale; TCI=topical calcineurin inhibitor; TCS=topical corticosteroid.

References: 1. Ständer S, Elmariah SB, Kwatra SG, et al. Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies. J Eur Acad Dermatol Venereol. 2025;00:1–9. doi:10.1111/jdv.70250 2. Augustin M, Tauber M, Sidbury R, et al. Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study. J Eur Acad Dermatol Venereol. 2025;00:1–15. doi:10.1111/jdv.70080 3. Legat FJ, Kwatra SG, Reich A, et al. Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis. J Eur Acad Dermatol Venereol. 2025;00:1–13. doi:10.1111/jdv.70266 4. NEMLUVIO (nemolizumab-ilto) Injection 30 mg Prescribing Information. Dallas, TX: Galderma Laboratories, L.P. 5. Galderma Laboratories, L.P.; data on file.

Important Safety Information

Indications: NEMLUVIO® (nemolizumab-ilto) is a prescription medicine used:

  • to treat adults and children 12 years of age and older with moderate-to-severe eczema (atopic dermatitis or AD) in combination with prescription therapies used on the skin (topical) when the eczema is not well controlled by topical therapies alone. It is not known if NEMLUVIO is safe and effective in children with atopic dermatitis under 12 years of age.
  • to treat adults with prurigo nodularis. It is not known if NEMLUVIO is safe and effective in children with prurigo nodularis under 18 years of age.

Do not take NEMLUVIO if you are allergic to nemolizumab-ilto or to any ingredients in NEMLUVIO. Before taking NEMLUVIO, tell your healthcare provider about all of your medical conditions, including if you:

  • are scheduled to receive any vaccination. You should not receive a live vaccine right before or during treatment with NEMLUVIO.
  • are pregnant or plan to become pregnant. It is not known whether NEMLUVIO will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known whether NEMLUVIO passes into your breast milk and if it can harm your baby.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

NEMLUVIO may cause serious side effects, including: allergic reactions (hypersensitivity). Stop using NEMLUVIO and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:

  • Breathing problems or wheezing
  • Swelling of the face, lips, mouth, tongue, or throat
  • Fainting, dizziness, feeling lightheaded
  • Fast pulse
  • Swollen lymph nodes
  • Joint pain
  • Fever
  • Skin rash (red or rough skin)
  • Nausea or vomiting
  • General ill feeling
  • Cramps in your stomach area

The most common side effects of NEMLUVIO include:

  • Eczema: headache, joint pain, hives (itchy red rash or wheals), and muscle aches
  • Prurigo Nodularis: headache and skin rashes: atopic dermatitis (a type of eczema), eczema, and eczema nummular (scattered circular patches)

These are not all of the possible side effects of NEMLUVIO.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information.